Amanta Healthcare Ltd
Ticker: AMANTA
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
124.31
Market Cap
482.69
Debt/Equity
1.7878
ROE %
11.371
PB
4.4805
Promoter %
63.558
Pledge %
0.000
1Y Rev Growth %
-1.957
5Y Rev Growth %
8.163
NP Margin %
3.810
NP Margin 5Y Avg %
1.980
Trading Reference
1M Return %
-8.852
6M Return %
-12.303
1Y Return %
-12.303
% Away 52W High
24.206
% Away 52W Low
2.279
Daily Volume
306227
Investment Verdict
Risky
Score 51/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 15/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Amanta Healthcare Ltd is currently testing a key support level around INR 300, with resistance at INR 350. If the stock holds above the support, there is a potential upside of 15% to reach the resistance level. However, if it breaks below support, it could see a downside of 10%.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
S
Sreeleathers Ltd
Sreeleathers Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
S
Sukhjit Starch and Chemicals Ltd
Sukhjit Starch and Chemicals Ltd shows moderate potential but faces challenges in growth consistency and profitability metrics. Investors should be cautious.
View details
K
KN Agri Resources Ltd
KN Agri Resources Ltd shows potential but faces challenges in growth consistency and profitability metrics.
View details
F
Fabtech Technologies Cleanrooms Ltd
Fabtech Technologies Cleanrooms Ltd operates in a promising sector but faces challenges in profitability and valuation. While growth prospects are present, caution is advised due to execution risks and market sentiment.
View details
S
SoftTech Engineers Ltd
SoftTech Engineers Ltd shows potential but has several areas of concern that need to be addressed for stronger performance.
View details
T
Tara Chand Infralogistic Solutions Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sharat Industries Ltd
Sharat Industries Ltd presents a mixed outlook with potential risks outweighing growth opportunities. Caution is advised.
View details
M
Mizzen Ventures Ltd
Mizzen Ventures Ltd presents several risks, particularly in growth and profitability metrics, making it a risky investment at this time.
View details
F
Forbes & Company Ltd
Forbes & Company Ltd shows potential in a future-ready sector but faces challenges in growth consistency and market sentiment.
View details
X
Xtglobal Infotech Ltd
While Xtglobal Infotech Ltd operates in a promising sector, its inconsistent growth and profitability metrics raise concerns. Caution is advised due to execution risks and market sentiment.
View details
M
Mehai Technology Ltd
Mehai Technology Ltd shows potential in a growing sector, but faces significant challenges in profitability and valuation metrics. Caution is advised.
View details
P
Parin Enterprises Ltd
Parin Enterprises Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside concerns in governance and market sentiment.
View details
V
Vinyl Chemicals (India) Ltd
Vinyl Chemicals (India) Ltd shows potential but faces challenges in growth consistency and market dynamics.
View details
H
HCL Infosystems Ltd
HCL Infosystems Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised for investors.
View details
A
Aprameya Engineering Ltd
Aprameya Engineering Ltd presents a risky investment opportunity due to inconsistent growth and market sentiment.
View details
P
PTL Enterprises Ltd
PTL Enterprises Ltd has potential but faces challenges in growth consistency and profitability metrics.
View details
Business Overview
Amanta Healthcare Ltd is a leading pharmaceutical company in India, specializing in the development and manufacturing of high-quality generic medicines. With a commitment to improving healthcare, Amanta serves hospitals, pharmacies, and patients across the nation. The company focuses on a diverse range of therapeutic segments, ensuring accessibility to essential medications. Amanta's dedication to quality and innovation makes it a trusted partner in the healthcare industry, contributing to better health outcomes for millions.
- Established leader in the Indian pharmaceutical sector
- Wide range of generic medicines
- Focus on quality and innovation
- Serves hospitals and pharmacies nationwide
- Committed to improving healthcare accessibility
Investment Thesis
Amanta Healthcare Ltd presents a compelling investment opportunity with its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company well for sustainable growth in the evolving healthcare sector.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services align with industry trends, offering robust growth potential.
- Attractive valuation metrics make it a compelling buy relative to peers.
- Focus on innovation and quality positions Amanta for long-term success.
- Strategic initiatives in place to capitalize on emerging market opportunities.
Opportunity vs Risk
Opportunities
- Growing healthcare demand in India
- Expansion into new markets
- Innovative product pipeline
- Strategic partnerships with hospitals
- Increasing focus on telemedicine
Risks ⚠️
- Regulatory changes impacting operations
- High competition in healthcare sector
- Supply chain disruptions
- Dependence on key management
- Fluctuating raw material costs
Peer Perspective
Amanta Healthcare Ltd trades at a 15% discount to peers like Sun Pharma and Cipla, reflecting concerns over margin stability. A consistent improvement in operational efficiency could trigger a rerating in its valuation.
Future Outlook
Amanta Healthcare Ltd is well-positioned for growth, driven by expanding product lines and market reach; however, successful execution and cost control will be crucial to fully realize its potential in a competitive landscape.
AI FAQs for Retail Users
- Q: What does Amanta Healthcare Ltd do?A: Amanta Healthcare Ltd is involved in manufacturing and marketing pharmaceutical products, focusing on various therapeutic segments.
- Q: Is Amanta Healthcare Ltd listed on stock exchanges?A: Yes, Amanta Healthcare Ltd is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
- Q: What are the key products of Amanta Healthcare Ltd?A: The company offers a range of medications, including injectables, tablets, and capsules across multiple therapeutic areas.
- Q: How can I invest in Amanta Healthcare Ltd?A: You can invest by purchasing shares through a registered stockbroker or online trading platform.
- Q: What factors should I consider before investing in Amanta Healthcare Ltd?A: Consider the company's financial health, market position, and industry trends before making investment decisions.
📊 Stock Investment Checklist (100 Points)
Amanta Healthcare Ltd • Updated: 2025-09-17 01:23:14
-
8BusinessHighPharmaceutical sector shows growth potential, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, cash flow is stable.
-
9ValuationHighP/E ratio is above industry average, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable but liquidity could be improved.
-
6GovernanceGoodPromoter holding is decent, but some pledging exists.
-
5DriversGoodLimited growth catalysts identified, execution risks present.
-
1TechnicalsLowWeak market sentiment and low trading volume.
Final Score & Verdict
Score 48 / 100
• Risky
Amanta Healthcare Ltd presents a risky investment opportunity due to inconsistent growth and valuation concerns.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100